Connor, Clark & Lunn Investment Management Ltd.
Position in ZTS — Zoetis Inc.
CIK 1596800
VANCOUVER, A1
Position in ZTS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$22,144,161
-$20,804,873 QoQ
Shares Held
187,329
-45.1% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $123,963,967 across 16 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
649,629 | $31,279,636 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
187,329 | $22,144,161 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
153,755 | $20,255,683 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
471,891 | $14,213,356 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
868,325 | $12,069,717 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
1,835,424 | $6,442,338 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
648,377 | $5,381,529 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
382,976 | $5,304,217 |
All Filings in ZTS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,144,161 | 187,329 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $42,949,034 | 341,353 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $53,984,764 | 368,950 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $29,299,106 | 187,875 | Shares | Sole | 2025-08-07 | |
| 2024-12-31 | $8,709,586 | 53,456 | Shares | Sole | 2025-02-10 | |
| 2024-06-30 | $84,132,128 | 485,303 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $91,671,209 | 541,760 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $17,865,537 | 90,518 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,327,067 | 53,610 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $471,744 | 3,219 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $294,652 | 1,987 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $385,549 | 2,243 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,066,192 | 10,956 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $219,871 | 901 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $26,771,906 | 137,900 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $39,132,618 | 209,984 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $37,009,217 | 235,009 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $23,403,851 | 141,413 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $12,366,699 | 74,782 | Shares | Sole | 2020-11-12 | |
| 2020-03-31 | $2,761,948 | 23,468 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||